Cervical cancer: an overview of pathophysiology and management

CA Johnson, D James, A Marzan, M Armaos - Seminars in oncology …, 2019 - Elsevier
Objective To provide an overview of the etiology, prevention, diagnosis, treatment, and long-
term survivorship concerns surrounding cervical cancer. Data Sources A review of articles …

[HTML][HTML] Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy

RA Mustafa, N Santesso, R Khatib, AA Mustafa… - International Journal of …, 2016 - Elsevier
Background Cervical cancer screening is offered to women to identify and treat cervical
intraepithelial neoplasia (CIN). Objectives To support WHO guidelines, a systematic review …

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

M Arbyn, SB Smith, S Temin, F Sultana, P Castle - Bmj, 2018 - bmj.com
Objective To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV)
assays on self samples and the efficacy of self sampling strategies to reach underscreened …

Worldwide initiatives to eliminate cervical cancer

S Wilailak, M Kengsakul… - International Journal of …, 2021 - Wiley Online Library
Abstract In 2020, more than 600 000 women were diagnosed with cervical cancer and 342
000 women died worldwide. Without comprehensive control, rates of cervical cancer …

Detection of solid tumor molecular residual disease (MRD) using circulating tumor DNA (ctDNA)

RI Chin, K Chen, A Usmani, C Chua, PK Harris… - Molecular diagnosis & …, 2019 - Springer
Circulating tumor DNA (ctDNA) is a component of cell-free DNA that is shed by malignant
tumors into the bloodstream and other bodily fluids. Levels of ctDNA are typically low …

[HTML][HTML] Educational interventions for cervical cancer screening behavior of women: a systematic review

MSG Naz, N Kariman, A Ebadi, G Ozgoli… - Asian Pacific journal …, 2018 - ncbi.nlm.nih.gov
Background: Cervical cancer is the second most common cancer in women worldwide; early
detection can play a key role in reducing the associated morbidity. The objective of this study …

World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen‐and‐treat strategies to prevent cervical cancer

N Santesso, RA Mustafa… - … of Gynecology & …, 2016 - Wiley Online Library
Background It is estimated that 1%–2% of women develop cervical intraepithelial neoplasia
grade 2–3 (CIN 2–3) annually worldwide. The prevalence among women living with HIV is …

Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis

H Camara, Y Zhang, L Lafferty, AJ Vallely, R Guy… - BMC Public Health, 2021 - Springer
Background Cervical cancer is the fourth most common cancer affecting women worldwide,
with 85% of the burden estimated to occur among women in low and middle-income …

Eliminating cervical cancer: progress and challenges for high-income countries

JC Davies-Oliveira, MA Smith, S Grover, K Canfell… - Clinical Oncology, 2021 - Elsevier
Abstract In 2020, the World Health Organization launched a major initiative to eliminate
cervical cancer globally. The initiative is built around the three key pillars of human …

Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: a multicenter, clinical-based, observational study

H Bao, H Bi, X Zhang, Y Zhao, Y Dong, X Luo… - Gynecologic …, 2020 - Elsevier
Objective Artificial intelligence (AI) could automatedly detect abnormalities in digital
cytological images, however, the effect in cervical cancer screening is inconclusive. We aim …